Total plasma homocysteine and primary open-angle glaucoma

American Journal of Ophthalmology

Volumn 137, Issue 3, 2004, Pages 401-406

  Wang, Gloria ^a   Medeiros, Felipe A ^a   Barshop, Bruce A ^b   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLAUCOMA, OPEN-ANGLE; HOMOCYSTEINE; HUMANS; MALE;

EID: 1542267398     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.09.041     Document Type: Article

References (44)

1. Hayreh S.S. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 20:2001;595-624.
2. Weinreb R.N., Cioffi G.A., Harris A. Optic nerve blood flow. Van Buskirk E.M., Shields B. 100 Years of progress in glaucoma. 1997;59-78 Lippincott-Raven Healthcare, Philadelphia.
3. Flammer J., Orgul S., Costa V.P., et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 21:2002;359-393.
4. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
5. McCully K.S. Vascular pathology of homocysteinemia Implications for the pathogenesis of arteriosclerosis. Am J Pathol. 56:1969;111-128.
6. Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., Shaper A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1995;1395-1398.
7. Ueland P.M., Refsum H., Brattstrom L. Plasma homocysteine and cardiovascular disease. Francis R.B.J. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. 1992;183-236 Marcel Dekker, New York.
8. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia an independent risk factor for vascular disease. N Engl J Med. 324:1991;1149-1355.
9. Selhub J., Jacques P.F., Bostom A.G., et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 332:1995;286-291.
10. Biousse V., Newman N.J., Sternberg P. Jr. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia. Am J Ophthalmol. 124:1997;257-260.
11. Cahill M., Karabatzaki M., Meleady R., et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol. 84:2000;154-157.
12. Salomon O., Moisseiev J., Rosenberg N., et al. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinol. 9:1998;617-622.
13. Pianka P., Almog Y., Man O., Goldstein M., Sela B.A., Loewenstein A. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 107:2000;1588-1592.
14. Loewenstein A., Goldstein M., Winder A., Lazar M., Eldor A. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology. 106:1999;1817-1820.
15. Loewenstein A., Winder A., Goldstein M., Lazar M., Eldor A. Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol. 124:1997;840-841.
16. Weger M., Stanger O., Deutschmann H., et al. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol. 134:2002;57-61.
17. Brown B.A., Marx J.L., Ward T.P., et al. Homocysteine a risk factor for retinal venous occlusive disease. Ophthalmology. 109:2002;287-290.
18. Biousse V., Kerrison J.B., Newman N.J. Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine? Br J Ophthalmol. 84:2000;555.
19. Leibovitch I., Kurtz S., Shemesh G., et al. Hyperhomocystinemia in pseudoexfoliation glaucoma. J Glaucoma. 12:2003;36-39.
20. Bleich S., Junemann A., Von Ahsen N., et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm. 109:2002;1499-1504.
21. Ducros V., Demuth K., Sauvant M.P., et al. Methods for homocysteine analysis and biological relevance of the results. J Chromatogr B Analyt Technol Biomed Life Sci. 781:2002;207-226.
22. Nexo E., Engbaek F., Ueland P.M., et al. Evaluation of novel assays in clinical chemistry quantification of plasma total homocysteine. Clin Chem. 46:2000;1150-1156.
23. Ducros V., Candito M., Causse E., et al. Comparison of plasma total homocysteine determinations in 9 French hospital laboratories by using 6 different methods. Ann Biol Clin (Paris). 60:2002;421-428.
24. Jacobsen D.W., Gatautis V.J., Green R. Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection. Anal Biochem. 178:1989;208-214.
25. Clarke R., Stansbie D. Assessment of homocysteine as a cardiovascular risk factor in clinical practice. Ann Clin Biochem. 38:2001;624-632.
26. Jacobsen D.W., Gatautis V.J., Green R., et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem. 40:1994;873-881.
27. Frigge M., Hoaglin D.C., Iglewicz B. Some implementations of the boxplot. The Am Statist. 43:1989;50-54.
28. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med. 49:1998;31-62.
29. Centers for Disease Control and Prevention. Assessment of laboratory tests for plasma homocysteine - selected laboratories, July-September 1998. MMWR 1999;48:1013-1015.
30. Malinow M.R., Bostom A.G., Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 99:1999;178-182.
31. Sutton-Tyrrell K., Bostom A., Selhub J., Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation. 96:1997;1745-1749.
32. Stamler J.S., Osborne J.A., Jaraki O., et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:1993;308-318.
33. Tsai J.C., Perrella M.A., Yoshizumi M., et al. Promotion of vascular smooth muscle cell growth by homocysteine a link to atherosclerosis. Proc Natl Acad Sci USA. 91:1994;6369-6373.
34. Tang L., Mamotte C.D., Van Bockxmeer F.M., Taylor R.R. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle. Atherosclerosis. 136:1998;169-173.
35. Rodgers G.M., Conn M.T. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 75:1990;895-901.
36. Rodgers G.M., Kane W.H. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest. 77:1986;1909-1916.
37. Moore P., El-sherbeny A., Roon P., Schoenlein P.V., Ganapathy V., Smith S.B. Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 73:2001;45-57.
38. Lipton S.A., Kim W.K., Choi Y.B., et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA. 94:1997;5923-5928.
39. Kim W.K., Pae Y.S. Involvement of N-methyl-d-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett. 216:1996;117-120.
40. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 285:2001;2481-2485.
41. Chasan-Taber L., Selhub J., Rosenberg I.H., et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr. 15:1996;136-143.
42. O'Grady H., Kelly C., Bouchier-Hayes D., Leahy A. Homocysteine and occlusive arterial disease. Br J Surg. 89:2002;838-844.
43. Verhoef P., Hennekens C.H., Allen R.H., Stabler S.P., Willett W.C., Stampfer M.J. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol. 79:1997;799-801.
44. Ford E.S., Smith S.J., Stroup D.F., Steinberg K.K., Mueller P.W., Thacker S.B. Homocyst(e)ine and cardiovascular disease a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol. 31:2002;59-70.